Přehled studií citovaných v článcích tohoto čísla Kardiologické revue

Česká verzia

Vyšlo v časopise: Kardiol Rev Int Med 2006, 8(3): 147

ASCOT-LLA –⁠ Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm
ASPEN –⁠ Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent Diabetes Mellitus
BARI II –⁠ Bypass Angioplasty Revascularization Investigation II
BETACAR –⁠ Betaxolol versus Carvedilol in Chronic Heart Failure
BIPS –⁠ Bezafibrat Infarction Prevention Study
CAPRICORN –⁠ Carvedilol Post Infarct Survival Control in LVD
CAPRIE –⁠ Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE) study
CARDS –⁠ Collaborative Atorvastatin Diabetes Study
CARE –⁠ Cholesterol And Recurrent Events
CIBIS II –⁠ The Second Cardiac Insufficiency Bisoprolol Study
CLARITY –⁠ Cladribine Tablets in Treating MS Orally Study
COMET –⁠ Carvedilol or Metoprolol European Trial Study
COMMIT/CCS-2 –⁠ Clopidogrel and Metoprolol in Myocardial Infarction Trial Study
COPERNICUS –⁠ Carvedilol Prospective Randomized Cumulative Survival
CREDO –⁠ The Clopidogrel for the Reduction of Events During Observation Study
CURE –⁠ The Clopidogrel in Unstable Angina to Prevent Recurrent Events
DAIS –⁠ Diabetes Atherosclerosis Intervention Study
DCCT –⁠ Diabetes Control and Complications Trial Study
DIGAMI –⁠ Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction
DIGAMI II –⁠ Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction 2
EDIC –⁠ Epidemiology of Diabetes Interventions and Complications Study
ETDRS –⁠ Early Treatment Diabetic Retinopathy Study
EUROPA –⁠ European Trial on Reduction of Cardiac Events with Perindopril in Stable Artery Coronary Disease
FIELD –⁠ Fenofibrate Intervention and Event Lowering in Diabetes
GREACE –⁠ Greek Atorvastatin and Coronary-heart-disease Evaluation
HOPE –⁠ Heart Outcomes Prevention Study
HPS –⁠ Heart Protection Study
CHARISMA –⁠ Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance
ISAR –⁠ Diabetes Study Paclitaxel-eluting and Sirolimus-eluting stents to Prevent Restenosis in Diabetic Patients
ISIS-1 –⁠ Second International Study of Infarct Survival
LATE-BASKET –⁠ Late Clinical Events Related to Late Stent Thrombosis After Stopping Clopidogrel: Drug-Eluting vs Bare-Metal Stenting
LIPID –⁠ Long-term Intervention with Pravastatin in Ischemic Disease
MADIT II –⁠ Multicenter Automatic Defibrillator Implantation Trial II
MERIT HF –⁠ The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure Study
MIAMI –⁠ Metoprolol in Acute Myocardial Infarction Study
MIRACLE –⁠ Multicenter InSync Randomized Clinical Evaluation
ONTARGET –⁠ Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Study
PEACE –⁠ Prevention of Events with Angiotensin-Converting Enzyme Inhibition
PHS –⁠ Physicians’ Health Study
POPADAD –⁠ The Prevention of Progression of Asymptomatic Diabetic Arterial Disease Study
PPP –⁠ Primary Prevention Project
PROACTIVE –⁠ Prospective Pioglitazone Clinical Trial in Macro Vascular Events
SCORE –⁠ The Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study
SENIORS –⁠ Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure
SIRIUS –⁠ SirolimUS-Eluting Stent in De Novo Native Coronary Lesions
STOP NIDDM –⁠ Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
TIMI-2B –⁠ Thrombolysis in Myocardial Infarction 2B Study
TNT –⁠ The Treating to New Targets
UKPDS –⁠ United Kingdom Prospective Diabetes Study
4S –⁠ Scandinavian Simvastatin Survival Study.